Professor of Stroke Medicine
- Chief Executive Officer, Oxford Academic Health Science Network
- Consultant Stroke Physician OUH
My work focuses on developing and evaluating treatments that can reduce brain damage in the first few hours after stroke, and developing better processes of care to deliver for stroke patients.
I have developed and evaluated the performance of stroke recognition instruments such as the Face Arm Speech Test (FAST) and Recognition of Stroke in the Emergency Room Scale (ROSIER) to improve early diagnosis of stroke by the public, ambulance paramedics and Emergency Department teams.
My work has evaluated the risks and benefits of thrombolysis in very elderly stroke patients 80 years or older, who are the population at highest risk of stroke.
In addition to my research in stroke my work more broadly seeks to understand the risks and benefits of drug therapies in older people.
National PReCePT Programme: a before-and-after evaluation of the implementation of a national quality improvement programme to increase the uptake of magnesium sulfate in preterm deliveries.
Edwards HB. et al, (2023), Arch Dis Child Fetal Neonatal Ed
Association of Blood Pressure Lowering Intensity With White Matter Network Integrity in Patients With Cerebral Small Vessel Disease
Pflanz CP. et al, (2022), Neurology, 10.1212/WNL.0000000000201018 - 10.1212/WNL.0000000000201018
Machine Learning-Based Identification of Target Groups for Thrombectomy in Acute Stroke.
Quandt F. et al, (2022), Translational stroke research
Cost-Effectiveness of Antihypertensive Deprescribing in Primary Care: a Markov Modelling Study Using Data From the OPTiMISE Trial.
Jowett S. et al, (2022), Hypertension
Improving emergency treatment for patients with acute stroke: the PEARS research programme, including the PASTA cluster RCT
Price CI. et al, (2022), Programme Grants for Applied Research, 10